Cyclometalated Iridium(III) Complexes with Optimally Allocated Excited-State Energy for Near-Infrared Photodynamic and Photothermal Therapy
Inorganic Chemistry · 22.09.2025 · 64 (37) · 19044-19054
DOI: 10.1021/acs.inorgchem.5c03265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 11.09.2025. Verfasst von Yun Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research and Development of Natural P…. Hauptthemen laut MEDLINE: Iridium, Coordination Complexes, Photochemotherapy, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Yunnan Provincial Science and Technology Department, Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Phosphorescent cyclometalated Ir(III) complexes can simultaneously generate reactive oxygen species and undergo photothermal conversion under light exposure, enabling synergistic photodynamic and photothermal therapy (PDT and PTT), and in vitro and in vivo bioimaging. However, how their light excitation properties and the distribution of excited-state (ES) energy across the photodynamic (energy or electron transfer), photothermal (nonradiative decay), and photoluminescent properties (radiative decay) determine their therapeutic and imaging efficacy are largely unclear. In this study, six Ir(III) complexes have been designed to explore the relationships between their structure and properties including ES energy level, population, and energy allocation. Through chemical, quantum chemical calculations, spectroscopic, and in vitro PDT/PTT for human malignant melanoma and cisplatin-resistant nonsmall-cell lung cancer, significant differences in activity and mechanisms were revealed among complexes with high structural similarity and the potential determining factors were systematically studied. In vivo, the selected complex Ir5 effectively inhibited the growth of cisplatin-resistant lung tumors by 96% and completely ablated 50% tumors in mice. This study provided not only single-molecule Ir(III) complexes for treatments of large, deep-seated, drug resistance tumors, but meaningful insights for the design of single molecules for synergistic PDT/PTT/bioimaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research and Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650500, P. R.…
- Animal Research and Resource Center, School of Life Sciences, Yunnan University, Kunming 650500, P. R. China.
ORCID-Profile: Feng Gao
Förderung
- Yunnan Provincial Science and Technology Department
- Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province
- National Natural Science Foundation of China
Zitieren
APA
Li, Y., Zheng, X. Q., Wang, D., Wei, C. L., Huang, Y. M., Han, M. C., Wang, Z. M., Li, X. L., Li, Q. F., Cai, Z., Ren, X., & Gao, F. (2025). Cyclometalated Iridium(III) Complexes with Optimally Allocated Excited-State Energy for Near-Infrared Photodynamic and Photothermal Therapy. Inorganic Chemistry, 64(37), 19044-19054. https://doi.org/10.1021/acs.inorgchem.5c03265
Vancouver
Li Y, Zheng XQ, Wang D, Wei CL, Huang YM, Han MC, et al. Cyclometalated Iridium(III) Complexes with Optimally Allocated Excited-State Energy for Near-Infrared Photodynamic and Photothermal Therapy. Inorganic Chemistry. 2025;64(37):19044-19054. doi:10.1021/acs.inorgchem.5c03265
BibTeX
@article{Li2025,
author = {Li, Yun and Zheng, Xiao-Qi and Wang, Ding and Wei, Chun-Lai and Huang, Ya-Man and Han, Meng-Chi and Wang, Ze-Ming and Li, Xue-Lian and Li, Qing-Fang and Cai, Zhongyan and Ren, Xiaoxia and Gao, Feng},
title = {Cyclometalated Iridium(III) Complexes with Optimally Allocated Excited-State Energy for Near-Infrared Photodynamic and Photothermal Therapy},
journal = {Inorganic Chemistry},
year = {2025},
volume = {64},
number = {37},
pages = {19044--19054},
doi = {10.1021/acs.inorgchem.5c03265}
}
EUVIMED